Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ketorolac | 3 | 2020 | 24 | 1.490 |
Why?
|
| Phacoemulsification | 3 | 2020 | 5 | 1.480 |
Why?
|
| Macular Edema | 2 | 2020 | 17 | 1.400 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 72 | 1.330 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 3 | 2012 | 4 | 1.200 |
Why?
|
| Phenylephrine | 3 | 2020 | 28 | 1.000 |
Why?
|
| Benzophenones | 2 | 2020 | 2 | 0.880 |
Why?
|
| Bromobenzenes | 2 | 2020 | 2 | 0.880 |
Why?
|
| Cataract | 2 | 2020 | 8 | 0.850 |
Why?
|
| Corneal Diseases | 3 | 2012 | 10 | 0.840 |
Why?
|
| Miosis | 2 | 2019 | 2 | 0.830 |
Why?
|
| Coloring Agents | 2 | 2012 | 29 | 0.810 |
Why?
|
| Fuchs' Endothelial Dystrophy | 2 | 2012 | 3 | 0.800 |
Why?
|
| Pseudophakia | 1 | 2020 | 3 | 0.710 |
Why?
|
| Prednisolone | 1 | 2020 | 9 | 0.700 |
Why?
|
| Corneal Edema | 2 | 2012 | 4 | 0.690 |
Why?
|
| Endothelium, Corneal | 4 | 2012 | 22 | 0.680 |
Why?
|
| Anterior Chamber | 1 | 2019 | 3 | 0.660 |
Why?
|
| Cataract Extraction | 1 | 2019 | 11 | 0.650 |
Why?
|
| Laser Therapy | 1 | 2019 | 55 | 0.630 |
Why?
|
| Visual Acuity | 5 | 2020 | 73 | 0.510 |
Why?
|
| Myopia | 2 | 2006 | 5 | 0.510 |
Why?
|
| Keratomileusis, Laser In Situ | 2 | 2006 | 3 | 0.510 |
Why?
|
| Corneal Stroma | 2 | 2012 | 6 | 0.500 |
Why?
|
| Cornea | 2 | 2006 | 16 | 0.500 |
Why?
|
| Postoperative Complications | 1 | 2020 | 780 | 0.480 |
Why?
|
| Gentian Violet | 1 | 2012 | 3 | 0.420 |
Why?
|
| Retrospective Studies | 7 | 2020 | 3510 | 0.420 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2012 | 3 | 0.410 |
Why?
|
| Photorefractive Keratectomy | 1 | 2012 | 3 | 0.410 |
Why?
|
| Tattooing | 1 | 2012 | 7 | 0.410 |
Why?
|
| Lasers, Excimer | 1 | 2012 | 8 | 0.410 |
Why?
|
| Descemet Membrane | 1 | 2012 | 4 | 0.410 |
Why?
|
| Iridocorneal Endothelial Syndrome | 1 | 2011 | 1 | 0.380 |
Why?
|
| Blister | 1 | 2011 | 7 | 0.380 |
Why?
|
| Hyaluronic Acid | 1 | 2011 | 52 | 0.370 |
Why?
|
| Aged | 7 | 2020 | 10314 | 0.340 |
Why?
|
| Contact Lenses | 2 | 2006 | 3 | 0.330 |
Why?
|
| Cosmetics | 2 | 2006 | 11 | 0.330 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 3990 | 0.330 |
Why?
|
| Male | 12 | 2020 | 19218 | 0.330 |
Why?
|
| Female | 11 | 2020 | 20016 | 0.320 |
Why?
|
| Humans | 16 | 2020 | 32115 | 0.320 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 288 | 0.320 |
Why?
|
| Aza Compounds | 1 | 2006 | 3 | 0.280 |
Why?
|
| Corneal Ulcer | 1 | 2006 | 2 | 0.280 |
Why?
|
| Quinolines | 1 | 2006 | 21 | 0.270 |
Why?
|
| Iris | 2 | 2019 | 6 | 0.270 |
Why?
|
| Lenses, Intraocular | 1 | 2006 | 1 | 0.270 |
Why?
|
| Optics and Photonics | 1 | 2006 | 7 | 0.270 |
Why?
|
| Acanthamoeba Keratitis | 1 | 2006 | 2 | 0.270 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 44 | 0.270 |
Why?
|
| Prosthesis-Related Infections | 1 | 2006 | 22 | 0.260 |
Why?
|
| Ophthalmic Solutions | 2 | 2020 | 2 | 0.250 |
Why?
|
| Middle Aged | 6 | 2020 | 11839 | 0.240 |
Why?
|
| Humidity | 1 | 2004 | 5 | 0.240 |
Why?
|
| Eye Burns | 1 | 2004 | 2 | 0.240 |
Why?
|
| Terpenes | 1 | 2004 | 7 | 0.240 |
Why?
|
| Explosions | 1 | 2004 | 12 | 0.230 |
Why?
|
| Burns, Chemical | 1 | 2004 | 7 | 0.230 |
Why?
|
| Temperature | 1 | 2004 | 55 | 0.230 |
Why?
|
| Blast Injuries | 1 | 2004 | 25 | 0.230 |
Why?
|
| Plant Extracts | 1 | 2004 | 61 | 0.220 |
Why?
|
| Algorithms | 1 | 2006 | 495 | 0.210 |
Why?
|
| Adult | 7 | 2020 | 9381 | 0.200 |
Why?
|
| Intraoperative Care | 1 | 2020 | 48 | 0.170 |
Why?
|
| Tissue Donors | 2 | 2012 | 198 | 0.170 |
Why?
|
| Postoperative Care | 1 | 2020 | 76 | 0.170 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2019 | 40 | 0.160 |
Why?
|
| Postoperative Period | 2 | 2011 | 97 | 0.160 |
Why?
|
| Meibomian Glands | 1 | 2017 | 1 | 0.140 |
Why?
|
| Eyelid Diseases | 1 | 2017 | 3 | 0.140 |
Why?
|
| Tears | 1 | 2017 | 2 | 0.140 |
Why?
|
| Dry Eye Syndromes | 1 | 2017 | 3 | 0.140 |
Why?
|
| Staining and Labeling | 1 | 2012 | 60 | 0.100 |
Why?
|
| Surgical Instruments | 1 | 2012 | 24 | 0.100 |
Why?
|
| Cell Count | 1 | 2011 | 47 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 2265 | 0.090 |
Why?
|
| Bioengineering | 1 | 2010 | 70 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2010 | 189 | 0.080 |
Why?
|
| Keratitis | 1 | 2006 | 3 | 0.070 |
Why?
|
| Fluoroquinolones | 1 | 2006 | 11 | 0.070 |
Why?
|
| Corneal Transplantation | 1 | 2006 | 14 | 0.070 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2006 | 2 | 0.070 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2006 | 2 | 0.070 |
Why?
|
| Antiprotozoal Agents | 1 | 2006 | 3 | 0.070 |
Why?
|
| Acanthamoeba | 1 | 2006 | 3 | 0.070 |
Why?
|
| Eye Infections, Bacterial | 1 | 2005 | 5 | 0.070 |
Why?
|
| Time Factors | 1 | 2011 | 2151 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2006 | 146 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 517 | 0.060 |
Why?
|
| Refraction, Ocular | 1 | 2004 | 2 | 0.060 |
Why?
|
| Limbus Corneae | 1 | 2004 | 7 | 0.060 |
Why?
|
| Microwaves | 1 | 2004 | 8 | 0.060 |
Why?
|
| Transplantation, Autologous | 1 | 2004 | 80 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2004 | 98 | 0.060 |
Why?
|
| Operating Rooms | 1 | 2004 | 35 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 765 | 0.060 |
Why?
|
| Reoperation | 1 | 2004 | 226 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2004 | 209 | 0.050 |
Why?
|
| Blepharitis | 1 | 2017 | 1 | 0.040 |
Why?
|
| Keratoconjunctivitis Sicca | 1 | 2017 | 2 | 0.040 |
Why?
|
| Risk Factors | 1 | 2004 | 3880 | 0.030 |
Why?
|
| Animals | 1 | 2006 | 7542 | 0.030 |
Why?
|
| Mechanical Phenomena | 1 | 2010 | 28 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 92 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 538 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 245 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 834 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 604 | 0.020 |
Why?
|
| Prosthesis Fitting | 1 | 2005 | 4 | 0.020 |
Why?
|
| Blindness | 1 | 2005 | 10 | 0.020 |
Why?
|
| Device Approval | 1 | 2005 | 6 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2005 | 20 | 0.020 |
Why?
|
| Adolescent | 1 | 2005 | 3569 | 0.010 |
Why?
|